Portfolio
Closing gaps in care and improving the lives of minority patients through technology-based patient engagement solutions which take into account the cultural and linguistic barriers patients face to understanding the complex world of healthcare.
Changing the way complex medicines are made and distributed by leveraging technology innovation to better serve scientific discovery, withstand disruptive events, and reach those in need.
Using AI to rapidly accelerate drug discovery and development for rare genetic diseases by predicting development outcomes upfront via proprietary disruptive technology.
Using state of the art antibody discovery and optimization strategies, Amagma selectively inhibits extracellular enzymes that, when overactive, can cause broad inflammatory response.
Safeguarding birth control through robust technology that addresses the pain points and obstacles of effective birth control.
Fighting to solve the opioid crisis and improve mental health by offering safe virtual reality digital therapeutics to treat acute and chronic pain and other diseases including anxiety and PTSD.
Developing first-in-class drugs that target dormant disseminated tumor cells (DTCs) to help prevent the recurrence of cancer.
Focused on improving mental health through the use of non-invasive neuromodulation devices which stimulate brain pathways and activate the body’s natural relaxation response, built on technology from Harvard Medical School, Rutgers and MIT.